1) Purchasing Options (Client-Facing Pricing Sheet) — EN

Brazil Pharma IP Threat Board 2026

Executive Intelligence Product | RPI 2859–2871

Coverage: Trademarks • Patents (PatBase-assisted) • Software • Technology Transfer

Format: PDF/DOCX + Figure Pack (PNG)

Positioning: Decision-grade BI/CI for Pharma, Consumer Health, OTC & Digital Health stakeholders entering or scaling in Brazil.

Choose Your License

Option A — Team License (Single Department)

Price: USD 1,900 (one-time)

Best for: In-house IP/Legal teams, Regulatory Affairs, or Strategy groups requiring internal use within one department.

Includes

• Full Executive Report (PDF + DOCX)
• Visual Figure Pack (PNG)
• 30-minute executive walkthrough (online)
• Email Q&A (up to 7 days after delivery)
• Optional bilingual executive summary (EN/PT)

Usage Rights

• Internal use by one department/team
• No redistribution outside the licensed department
• No external publication or resale

Option B — Enterprise License (Multi-Team Distribution)

Price: USD 4,900 (one-time)

Best for: Global companies requiring internal circulation across Legal, IP, Regulatory, BD/Strategy, and leadership teams.

Includes

• Everything in Option A, plus:
• Internal redistribution rights across multiple teams in the same company
• 60-minute executive workshop (online)
• Tailored “Executive Risk Takeaways” slide (1-page)
• Optional: consolidated watchlist rules (up to 20 targets)

Usage Rights

• Internal company-wide distribution allowed
• No resale or external publication

Option C — Monitoring + Opposition Readiness (Subscription)

Price: From USD 950/month (minimum 3 months)

Best for: Teams needing continuous early-warning signals and escalation-ready monitoring.

Includes

• Weekly trademark collision alerts (watchlist-based)
• Monthly patent barrier radar update (PatBase-assisted, family-level signal)
• Monthly technology-transfer & licensing early-signal brief
• Monthly executive summary (EN, PT optional)
• 1 escalation call/month (30 minutes)

Optional Add-Ons (priced separately)

• Draft-ready opposition brief (for selected conflicts)
• Therapeutic deep-dive module (GLP-1 / Oncology / Vaccines / Dermatology)
• Extended watchlists (>20 targets)

Option D — Research Publisher / Data Platform License (POA)

Pricing: Price on application (POA)

Best for: Global research publishers and data platforms seeking to enrich coverage and/or redistribute.

Typical Structures

• Internal research enrichment license (annual)
• Redistribution / resale license (annual)
• Co-branded or white-label editions
• Quarterly or monthly refresh options

Delivery Timeline

• Standard delivery: 2–5 business days after confirmation and payment
• Monitoring setup: 5–10 business days (depends on watchlist scope)

Payment Terms

• Payment in advance via invoice (USD)
• Bank transfer / Wise / equivalent accepted
• Subscription billed monthly in advance

Scope & Disclaimer

This report is designed for strategic intelligence and risk awareness.

It is not legal advice and does not replace a formal legal opinion.

Order / Contact

Marcus Julius Zanon — IP Lawyer & Compliance Officer (Brazil/LATAM)

🌐 www.mjzanon.com

✉️ [email protected]

📱 WhatsApp +55 41 99137-1456

💬 WeChat MJZANON-BRAZIL